Mirabegron 70710-1160
Product NDC
70710-1160- Manufacturer
- Zydus Pharmaceuticals (usa) Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 23, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA209488
Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 50 mg/1 |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(3)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-3)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-9)